表紙
市場調查報告書
商品編碼
1064730

心臟麻痺治療的全球市場:2021年∼2027年

Cardiac Arrest Treatment Market 2021-2027

出版日期: | 出版商: Orion Market Research Pvt Ltd | 英文 111 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球心臟麻痺治療的市場規模在預測期間內預計將以大幅年複合成長率擴大。久坐的生活方式習慣,肥胖,糖尿病,抽煙,高膽固醇,高血壓等,對全球心臟驟停治療市場的增長做出了重大貢獻。

本報告提供全球心臟麻痺治療市場相關調查,提供市場概要,以及各治療類型,各地區的趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

  • 調查範圍
  • 分析師的洞察和目前市場趨勢

第3章 市場決策要素

  • 促進因素
  • 阻礙因素
  • 市場機會

第4章 市場區隔

  • 全球心臟麻痺治療市場,各治療類型
    • 藥物
    • 醫療設備

第5章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他
  • 其他地區

第6章 企業簡介

  • Amgen, Inc.
  • Bayer AG
  • Boston Scientific Corp.
  • Bristol-Myers Squibb Company
  • Cardiac Science Corp.(Aurora Capital Group)
  • GE Healthcare
  • Johnson & Johnson
  • Koninklijke Philips N.V.
  • Novartis AG
  • Pfizer, Inc.
目錄
Product Code: OMR2024216

Global Cardiac Arrest Treatment Market Size, Share & Trends Analysis Report By Treatment Type (Drugs, Medical Devices), Forecast (2021 - 2027)

The global cardiac arrest treatment market is anticipated to grow at a considerable CAGR during the forecast period. Higher inclination towards sedentary lifestyle, obesity, diabetes mellitus, smoking, high cholesterol, and high blood pressure among others are the key contributors to the growth of the global cardiac arrest treatment market.

The global cardiac arrest treatment market is segmented based on treatment type. Based on treatment type, the cardiac arrest treatment market is segmented into drug and medical device. The drugs are further sub-segmented into vasopressors, corticosteroid, anti-arrhythmic drugs, and others. The medical device segment is further sub-segmented into defibrillator, cardiac resynchronization therapy, and others.

Geographically, the global cardiac arrest treatment market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World. Some of the companies operating in the global cardiac arrest treatment market include ZOLL Medical Corp., General Electric Co., Abbott Laboratories, Stryker Corp., Boston Scientific Corp., and Koninklijke Philips N.V. among others.

Market Segmentation

1. Global Cardiac Arrest Treatment Market Research and Analysis by Treatment Type

The Report Covers

  • Comprehensive research methodology of the global cardiac arrest treatment market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global cardiac arrest treatment market.
  • Insights about market determinants that are stimulating the global cardiac arrest treatment market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Market Determinants

  • 3.1. Motivators
  • 3.2. Restraints
  • 3.3. Opportunities

4. Market Segmentation

  • 4.1. Global Cardiac Arrest Treatment Market by Treatment Type
    • 4.1.1. Drugs
      • 4.1.1.1. Vasopressors
      • 4.1.1.2. Corticosteroid
      • 4.1.1.3. Anti-arrhythmic Drugs
      • 4.1.1.4. Others (Beta-blockers and Fibrinolytic drugs)
    • 4.1.2. Medical Devices
      • 4.1.2.1. Defibrillator
      • 4.1.2.2. Cardiac Resynchronization Therapy
      • 4.1.2.3. Others (Ventricular Assist Devices)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Amgen, Inc.
  • 6.2. Bayer AG
  • 6.3. Boston Scientific Corp.
  • 6.4. Bristol-Myers Squibb Company
  • 6.5. Cardiac Science Corp. (Aurora Capital Group)
  • 6.6. GE Healthcare
  • 6.7. Johnson & Johnson
  • 6.8. Koninklijke Philips N.V.
  • 6.9. Novartis AG
  • 6.10. Pfizer, Inc.

LIST OF TABLES

  • 1. GLOBAL CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2020-2027 ($ MILLION)
  • 2. GLOBAL DRUGS FOR CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 3. GLOBAL CAPSULES FOR CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)
  • 5. NORTH AMERICAN CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 6. NORTH AMERICAN CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2020-2027 ($ MILLION)
  • 7. NORTH AMERICAN CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 8. EUROPEAN CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 9. EUROPEAN CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2020-2027 ($ MILLION)
  • 10. EUROPEAN CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 11. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 12. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2020-2027 ($ MILLION)
  • 13. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 14. REST OF THE WORLD CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2020-2027 ($ MILLION)
  • 15. REST OF THE WORLD CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL CARDIAC ARREST TREATMENT MARKET SHARE BY TREATMENT TYPE, 2020 VS 2027 (%)
  • 2. GLOBAL CARDIAC ARREST TREATMENT MARKET SHARE BY APPLICATION, 2020 VS 2027 (%)
  • 3. GLOBAL CARDIAC ARREST TREATMENT MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 4. US CARDIAC ARREST TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 5. CANADA CARDIAC ARREST TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 6. UK CARDIAC ARREST TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 7. FRANCE CARDIAC ARREST TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 8. GERMANY CARDIAC ARREST TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 9. ITALY CARDIAC ARREST TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 10. SPAIN CARDIAC ARREST TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 11. REST OF EUROPE CARDIAC ARREST TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 12. INDIA CARDIAC ARREST TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 13. CHINA CARDIAC ARREST TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 14. JAPAN CARDIAC ARREST TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 16. REST OF THE WORLD CARDIAC ARREST TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)